ThinkstockOnce again, the Wall Street conference calendar is heating up. Next week is the widely attended Jefferies Global Healthcare Conference in New York City. Following the success of last year’s conference, with more than…
ThinkstockCerner Inc. (NASDAQ: CERN) is acting like the stock market is back to 1999 or 2000 all over again. Now that the healthcare solutions provider’s shares are up more than 20% so far in…
ThinkstockAffymax Inc. (NASDAQ: AFFY) has been in more than trouble. Its very future is at stake as far as investors (and speculators) are concerned. The company is restructuring, but this restructuring may be more…
ThinkstockThe world of biotech investing is always a difficult one. Often a binary event, such as U.S. Food and Drug Administration (FDA) approval or a life-saving capital raise, is the difference between not only…
Courtesy Herbalife Ltd.Shares of Herbalife Ltd. (NYSE: HLF) were halted briefly shortly before noon today as we all waited breathlessly for news. When the new arrived, well, how exciting can a new auditing firm…
ThinkstockThe world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug Administration (FDA) approval or a life-saving capital raise is the difference between not only…
via Wikimedia CommonsDendreon Corp. (NASDAQ: DNDN) has been facing problems getting its Provenge sales for advanced metastatic prostate cancer through to the market. Even a direct to consumer advertising campaign has so far failed…
ThinkstockBiotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and the AMEX Biotechnology index (BTK) is up 50%, versus the 28% gain for the…
ThinkstockMyriad Genetics Inc. (NASDAQ: MYGN) is seeing a benefit in its share price after actress Angelina Jolie wrote that a genetic test using Myriad’s gene sequencing tested positive for the gene with much higher…
ThinkstockOne of the downsides to a market that seems to go up every day is knowing what stocks to own or sell as the market chugs higher. One strategy for investors to consider is…
ThinkstockIn theory, medical technology companies should be some of the market’s best-performing stocks. After all, it’s not really a cyclical business, and price tags are rarely a stumbling block when insurance companies, the government…
ThinkstockDendreon Corp. (NASDAQ: DNDN) just cannot catch a break. Despite having what was supposed to be one of the best late-stage prostate treatments in Provenge, sales just are not coming in as expected. Dendreon’s…
Wikimedia CommonsYesterday’s announcement by Pfizer Inc. (NYSE: PFE) that it would begin selling its blockbuster Viagra drug online directly to patients is a genuinely ground-breaking deal. The big drug companies like Pfizer, Abbot Laboratories…
ThinkstockNow that Pfizer Inc. (NYSE: PFE) has started to sell Viagra online at Viagra.com, can Cialis.com and Levitra.com be far behind? These two other drugs face the same black market trouble Viagra does. Pfizer…
ThinkstockThe world of pharmaceuticals may have faced a patent cliff in recent years, but brand name drugs are still generating billions upon billions in annual sales in the United States alone. Some of these…